Investigation of inducing apoptosis in human lung cancer A549 cells and related mechanism of a ruthenium(II) polypyridyl complex |
| |
| Affiliation: | 1. Analysis Centre of Guangdong Medical University, Zhanjiang 524023, China;2. Guangdong Key Laboratory for Research and Development of Nature Drugs, Guangdong Medical University, Zhanjiang 524023, China;3. School of Pharmacy, Guangdong Medical University, Zhanjiang 524023, China;4. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China |
| |
| Abstract: | Two Ru(II) polypyridyl complexes [Ru(bpy)2(pztp)]2 + (Ru1) and [Ru(bpy)2(pytp)]2 + (Ru2) were synthesized and characterized. Our data demonstrated that Ru2 displayed relatively higher cytotoxic activity against lung cancer A549 cells and had higher selectivity between tumor and normal cells in comparison with cisplatin. Studies on the molecular mechanism revealed that Ru2 caused cell cycle arrest at G2/M in A549 cells and induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway. The further studies by comet assay at single cell level indicated that DNA damage in A549 cells was triggered by Ru2, following with the up-regulation of phosphorylated ATM (Ser1984), Histone H2A.X (Ser139) and p53 (Ser15). Western blot analysis suggested that MAPKs signaling pathways, especially ERK, were involved in Ru2-induced apoptosis. Moreover, both DNA damage and MAPKs signaling pathways were regulated by the level of ROS. To our knowledge, this is the first report of the ruthenium (II) polypyridyl complex which induces apoptosis partly through the activation of ERK. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
